200,000+ products from a single source!

sales@angenechem.com

Home > Quinoline > 91-21-4

91-21-4

91-21-4 | 1,2,3,4-Tetrahydroisoquinoline

CAS No: 91-21-4 Catalog No: AG003DA8 MDL No:MFCD00006896

Product Description

Catalog Number:
AG003DA8
Chemical Name:
1,2,3,4-Tetrahydroisoquinoline
CAS Number:
91-21-4
Molecular Formula:
C9H11N
Molecular Weight:
133.1903
MDL Number:
MFCD00006896
IUPAC Name:
1,2,3,4-tetrahydroisoquinoline
InChI:
InChI=1S/C9H11N/c1-2-4-9-7-10-6-5-8(9)3-1/h1-4,10H,5-7H2
InChI Key:
UWYZHKAOTLEWKK-UHFFFAOYSA-N
SMILES:
N1CCc2c(C1)cccc2
EC Number:
202-050-0
UNII:
56W89FBX3E
NSC Number:
15312

Properties

Complexity:
111  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
133.089g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
133.194g/mol
Monoisotopic Mass:
133.089g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
12A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.6  

Literature

Title Journal
The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 20140902
Bioactive alkaloid extracts from Narcissus broussonetii: mass spectral studies. Journal of pharmaceutical and biomedical analysis 20121101
Regiochemistry of the condensation of 2-aroyl-cyclohexanones and 2-cyanoacetamide: 13C-labeling studies and semiempirical MO calculations. The Journal of organic chemistry 20120907
Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold. European journal of medicinal chemistry 20120801
(S)-4-tert-Butyl-2-(1,2,3,4-tetra-hydro-isoquinolin-3-yl)-1,3-thia-zole. Acta crystallographica. Section E, Structure reports online 20120801
Synthesis and SAR of tetrahydroisoquinolines as Rev-erbα agonists. Bioorganic & medicinal chemistry letters 20120601
First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours. British journal of cancer 20120410
MCR synthesis of praziquantel derivatives. Chemical biology & drug design 20120401
Pictet-Spenglerase involved in tetrahydroisoquinoline antibiotic biosynthesis. Current opinion in chemical biology 20120401
Concise route to 3-arylisoquinoline skeleton by Lewis acid catalyzed C(sp3)-H bond functionalization and its application to formal synthesis of (±)-tetrahydropalmatine. Organic letters 20120316
Synthesis of a unique isoindoline/tetrahydroisoquinoline-based tricyclic sultam library utilizing a Heck-aza-Michael strategy. ACS combinatorial science 20120312
(S)-Benzyl 3-phenyl-carbamoyl-1,2,3,4-tetra-hydro-isoquinoline-2-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20120301
Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists. Journal of medicinal chemistry 20120223
Characterization of SfmD as a Heme peroxidase that catalyzes the regioselective hydroxylation of 3-methyltyrosine to 3-hydroxy-5-methyltyrosine in saframycin A biosynthesis. The Journal of biological chemistry 20120210
Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies. Cancer chemotherapy and pharmacology 20120201
Monitoring on-chip Pictet-Spengler reactions by integrated analytical separation and label-free time-resolved fluorescence. Chemistry (Weinheim an der Bergstrasse, Germany) 20120123
Libraries of 2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-amine derivatives via a multicomponent assembly process/1,3-dipolar cycloaddition strategy. ACS combinatorial science 20120109
(S)-4-Phenyl-2-(1,2,3,4-tetra-hydro-isoquinolin-3-yl)-1,3-thia-zole. Acta crystallographica. Section E, Structure reports online 20120101
The role of circulating serotonin in the development of chronic obstructive pulmonary disease. PloS one 20120101
Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PloS one 20120101
Genome expression profile analysis of the immature maize embryo during dedifferentiation. PloS one 20120101
Molecular network profiling of U373MG human glioblastoma cells following induction of apoptosis by novel marine-derived anti-cancer 1,2,3,4-tetrahydroisoquinoline alkaloids. Cancer cell international 20120101
A systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcoma. PloS one 20120101
Salsolinol facilitates glutamatergic transmission to dopamine neurons in the posterior ventral tegmental area of rats. PloS one 20120101
Trabectedin as a new chemotherapy option in the treatment of relapsed platinum sensitive ovarian cancer. Current pharmaceutical design 20120101
Acceleration of anaerobic cysteine transformations to sulfane sulfur consequent to γ-glutamyl transpeptidase inhibition. TheScientificWorldJournal 20120101
Borreria and Spermacoce species (Rubiaceae): A review of their ethnomedicinal properties, chemical constituents, and biological activities. Pharmacognosy reviews 20120101
A possible novel anti-inflammatory mechanism for the pharmacological prolyl hydroxylase inhibitor 3,4-dihydroxybenzoate: implications for use as a therapeutic for Parkinson's disease. Parkinson's disease 20120101
The Pictet-Spengler mechanism involved in the biosynthesis of tetrahydroisoquinoline antitumor antibiotics: a novel function for a nonribosomal peptide synthetase. Methods in enzymology 20120101
Electrochemical synthesis and chemistry of chiral 1-cyanotetrahydroisoquinolines. An approach to the asymmetric syntheses of the alkaloid (-)-crispine a and its natural (+)-antipode. The Journal of organic chemistry 20111202
Quantitative structure-activity relationship (QSAR) analysis of tumor-specificity of 1,2,3,4-tetrahydroisoquinoline derivatives. Anticancer research 20111201
(1R,3S)-N-Benzhydryl-2-benzyl-6,7-dimeth-oxy-1-phenyl-1,2,3,4-tetra-hydro-isoquinoline-3-carbothio-amide. Acta crystallographica. Section E, Structure reports online 20111201
CKD-712, (S)-1-(α-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, Inhibits the NF-κB Activation and Augments Akt Activation during TLR4 Signaling. Immune network 20111201
Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743. ACS chemical biology 20111118
Direct functionalization of (un)protected tetrahydroisoquinoline and isochroman under iron and copper catalysis: two metals, two mechanisms. The Journal of organic chemistry 20111104
A highly efficient and enantioselective access to tetrahydroisoquinoline alkaloids: asymmetric hydrogenation with an iridium catalyst. Angewandte Chemie (International ed. in English) 20111104
Melanin-concentrating hormone receptor 1 antagonists: synthesis, structure-activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives. Bioorganic & medicinal chemistry 20111101
Expedient entry to the piperazinohydroisoquinoline ring system using a sequential Ugi/Pictet-Spengler/reductive methylation reaction protocol. Chemical communications (Cambridge, England) 20111014
Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents. Bioorganic & medicinal chemistry letters 20111001
2-[(1R,3S)-6,7-Dimeth-oxy-1-phenyl-1,2,3,4-tetra-hydro-isoquinolin-3-yl]-4-phenyl-1,3-thia-zole. Acta crystallographica. Section E, Structure reports online 20111001
2-(2-Hy-droxy-phen-yl)-3,4-dihydro-iso-quinolin-1(2H)-one. Acta crystallographica. Section E, Structure reports online 20111001
2-(4-Bromo-phen-yl)-3,4-dihydro-isoquinolin-2-ium thio-cyanate hemihydrate. Acta crystallographica. Section E, Structure reports online 20111001
Identification of novel allosteric modulators for the G-protein coupled US28 receptor of human cytomegalovirus. Bioorganic & medicinal chemistry letters 20110915
Multicomponent assembly strategies for the synthesis of diverse tetrahydroisoquinoline scaffolds. Organic letters 20110902
XPF-dependent DNA breaks and RNA polymerase II arrest induced by antitumor DNA interstrand crosslinking-mimetic alkaloids. Chemistry & biology 20110826
Biocatalytic organic synthesis of optically pure (S)-scoulerine and berbine and benzylisoquinoline alkaloids. The Journal of organic chemistry 20110819
Eosin Y catalyzed visible light oxidative C-C and C-P bond formation. Organic letters 20110805
Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release. Neurotoxicity research 20110801
Modulation of leukotriene D4 attenuates the development of seizures in mice. Prostaglandins, leukotrienes, and essential fatty acids 20110801
2-(4-Iodo-phen-yl)-1,2,3,4-tetra-hydro-isoquinoline-1-carbonitrile. Acta crystallographica. Section E, Structure reports online 20110801
Structure-based design of novel boronic acid-based inhibitors of autotaxin. Journal of medicinal chemistry 20110714
Comparison of enveloping distribution sampling and thermodynamic integration to calculate binding free energies of phenylethanolamine N-methyltransferase inhibitors. The Journal of chemical physics 20110714
Dietary inhibitors of monoamine oxidase A. Journal of neural transmission (Vienna, Austria : 1996) 20110701
Asymmetric total synthesis of (-)-saframycin A from L-tyrosine. The Journal of organic chemistry 20110701
Ortho-rhom-bic polymorph of (6,7-dimeth-oxy-1,2,3,4-tetra-hydro-isoquinolin-1-yl)methanol. Acta crystallographica. Section E, Structure reports online 20110701
Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2). Bioorganic & medicinal chemistry letters 20110615
Evaluation of a chimeric (uPA+/+)/SCID mouse model with a humanized liver for prediction of human metabolism. Xenobiotica; the fate of foreign compounds in biological systems 20110601
6,7-Dimeth-oxy-3-meth-oxy-carbonyl-1-(2-meth-oxy-phen-yl)-3,4-dihydro-isoquinoline 2-oxide. Acta crystallographica. Section E, Structure reports online 20110601
(1S,3S)-Methyl 2-benzyl-6,7-dimeth-oxy-1-phenyl-1,2,3,4-tetra-hydro-isoquinoline-3-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20110601
2-(2-Iodo-phen-yl)-1,2,3,4-tetra-hydro-isoquinoline-1-carbonitrile. Acta crystallographica. Section E, Structure reports online 20110601
(1S,3S)-Methyl 6,7-dimeth-oxy-1-phenyl-1,2,3,4-tetra-hydro-isoquinoline-3-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20110601
Chiral capillary electrophoresis-mass spectrometry of tetrahydroisoquinoline-derived neurotoxins: observation of complex stereoisomerism. Journal of chromatography. A 20110520
1,5-Substituted nipecotic amides: selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability. Bioorganic & medicinal chemistry letters 20110515
(S)-2-Benzyl-N-(2,6-diisopropyl-phen-yl)-1,2,3,4-tetra-hydro-isoquinoline-3-carboxamide. Acta crystallographica. Section E, Structure reports online 20110501
Development of tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities. Journal of medicinal chemistry 20110428
A synthetic route to highly substituted 1,2,3,4-tetrahydroisoquinolines via Yb(OTf)3 -catalyzed diastereoselective ring opening of bridged oxazolidines: asymmetric synthesis of 2-azapodophyllotoxin. Chemistry (Weinheim an der Bergstrasse, Germany) 20110418
Design and evaluation of fragment-like estrogen receptor tetrahydroisoquinoline ligands from a scaffold-detection approach. Journal of medicinal chemistry 20110414
Methyl 1-cyclo-hexyl-6,7-dimeth-oxy-3,4-dihydro-isoquinoline-3-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20110401
Phosphate mediated biomimetic synthesis of tetrahydroisoquinoline alkaloids. Chemical communications (Cambridge, England) 20110321
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs. Bioorganic & medicinal chemistry letters 20110315
Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists. Bioorganic & medicinal chemistry letters 20110301
Optically active diaryl tetrahydroisoquinoline derivatives. Acta crystallographica. Section C, Crystal structure communications 20110301
[Design, synthesis, and PPARalpha/gamma agonistic activity of novel tetrahydroisoquinoline derivatives]. Yao xue xue bao = Acta pharmaceutica Sinica 20110301
Synthesis of anisotropic CdS nanostructures via a single-source route. Journal of nanoscience and nanotechnology 20110201
Discovery of isoindoline and tetrahydroisoquinoline derivatives as potent, selective PPARδ agonists. Bioorganic & medicinal chemistry letters 20110101
Structure-activity relationship (SAR) of the α-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists. Bioorganic & medicinal chemistry letters 20110101
Liposarcoma: molecular genetics and therapeutics. Sarcoma 20110101
In silico quantitative structure-activity relationship studies on P-gp modulators of tetrahydroisoquinoline-ethyl-phenylamine series. BMC structural biology 20110101
Anticancer and antimetastatic activities of Renieramycin M, a marine tetrahydroisoquinoline alkaloid, in human non-small cell lung cancer cells. Anticancer research 20110101
Isolation of salsolinol, a tetrahydroisoquinoline alkaloid, from the marine sponge Xestospongia cf. vansoesti as a proteasome inhibitor. Chemical & pharmaceutical bulletin 20110101
The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease. International journal of molecular sciences 20110101
1-(2-Bromobenzoyl)-6,7-(methylene-dioxy)isoquinoline. Acta crystallographica. Section E, Structure reports online 20110101
N-(9,11-Dimeth-oxy-4-oxo-2,3,4,6,7,11b-hexa-hydro-1H-pyrido[2,1-a]isoquinolin-3-yl)benzamide. Acta crystallographica. Section E, Structure reports online 20110101
(3S)-2-Benzyl-3-carb-oxy-1,2,3,4-tetra-hydro-isoquinolinium chloride monohydrate. Acta crystallographica. Section E, Structure reports online 20110101
(S)-N-Benzyl-2-methyl-1,2,3,4-tetra-hydro-isoquinoline-3-carboxamide. Acta crystallographica. Section E, Structure reports online 20110101
Feasibility Assessment of Micro-Electrode Chip Assay as a Method of Detecting Neurotoxicity in vitro. Frontiers in neuroengineering 20110101
Global diversity of Ascidiacea. PloS one 20110101
Synthesis and pharmacological evaluation of 1-isopropyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel antihypertensive agents. Chemical & pharmaceutical bulletin 20110101
ROCKing Regeneration: Rho Kinase Inhibition as Molecular Target for Neurorestoration. Frontiers in molecular neuroscience 20110101
Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment. Marine drugs 20110101
Investigational approaches for mesothelioma. Frontiers in oncology 20110101
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants. Chemical & pharmaceutical bulletin 20101201
(1R,3S)-Methyl 6,7-dimeth-oxy-1-(4-meth-oxy-phen-yl)-1,2,3,4-tetra-hydro-isoquinoline-3-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20101201
4-Chloro-N-methyl-2-(1,2,3,4-tetra-hydro-isoquinolin-1-yl)aniline. Acta crystallographica. Section E, Structure reports online 20101201
Design, synthesis, and in vitro evaluation of potential West Nile virus protease inhibitors based on the 1-oxo-1,2,3,4-tetrahydroisoquinoline and 1-oxo-1,2-dihydroisoquinoline scaffolds. Journal of combinatorial chemistry 20101108
A suitable preparation of N-sulfonyl-1,2,3,4-tetrahydroisoquinolines and their ring homologs with a reusable Preyssler heteropolyacid as catalyst. Molecular diversity 20101101
The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptors. Molecular pharmacology 20101101
PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity. British journal of pharmacology 20101101
Total synthesis of (+)-korupensamine B via an atropselective intermolecular biaryl coupling. Journal of the American Chemical Society 20101013
A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors. Nature communications 20101005
An unusual reactivity of BBr(3): Accessing tetrahydroisoquinoline units from N-phenethylimides. Organic & biomolecular chemistry 20100921
Specific inhibitors of the breast cancer resistance protein (BCRP). ChemMedChem 20100903
Synthesis, structure and DNA cleavage studies of coumarin analogues of tetrahydroisoquinoline and protoberberine alkaloids. European journal of medicinal chemistry 20100901
Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonists. Bioorganic & medicinal chemistry letters 20100901
Synthesis of novel tetrahydroisoquinoline bronchodilators. Bioorganic & medicinal chemistry letters 20100901
Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms. Experimental neurobiology 20100901
Recent synthetic approaches to 6,15-iminoisoquino[3,2-b]3-benzazocine compounds. Chemistry (Weinheim an der Bergstrasse, Germany) 20100823
Synthesis of tetrahydroisoquinoline alkaloids via anodic cyanation as the key step. The Journal of organic chemistry 20100820
Tetrahydroisoquinoline derivatives as highly selective and potent Rho kinase inhibitors. Journal of medicinal chemistry 20100812
Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin. Bioorganic & medicinal chemistry letters 20100801
A review of trabectedin (ET-743): a unique mechanism of action. Molecular cancer therapeutics 20100801
Novel tetrahydroisoquinoline derivatives with inhibitory activities against acyl-CoA: cholesterol acyltransferase and lipid peroxidation. Chemical & pharmaceutical bulletin 20100801
Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Eschscholzia californica (Papaveraceae). Natural product communications 20100701
Catechol-O-methyltransferase: potential relationship to idiopathic hypertension. Archives of medical science : AMS 20100630
4-[(2,4-Dimethyl-1,3-oxazol-5-yl)meth-yl]-4-hydr-oxy-2-methyl-isoquinoline-1,3(2H,4H)-dione. Acta crystallographica. Section E, Structure reports online 20100401
2'-Methyl-3,5-diphenyl-spiro-[4,6-dioxa-2-aza-bicyclo-[3.2.0]hept-2-ene-7,4'-iso-quinoline]-1',3'(2'H,4'H)-dione. Acta crystallographica. Section E, Structure reports online 20100401
4-[(2,4-Dimethyl-thia-zol-5-yl)meth-yl]-4-hydr-oxy-2-methyl-isoquinoline-1,3(2H,4H)-dione. Acta crystallographica. Section E, Structure reports online 20100401
4-[(2,5-Dimethyl-1,3-thia-zol-4-yl)meth-yl]-4-hydr-oxy-2-methyl-isoquinoline-1,3(2H,4H)-dione. Acta crystallographica. Section E, Structure reports online 20100401
Catalytic enantioselective 1,3-dipolar cycloaddition of C,N-cyclic azomethine imines with alpha,beta-unsaturated aldehydes. Journal of the American Chemical Society 20100331
Preventative effects of 1,3-dimethyl- and 1,3-dimethyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline on MPTP-induced Parkinson's disease-like symptoms in mice. Brain research 20100319
Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds. Bioorganic & medicinal chemistry letters 20100301
Novel pyrazolo-tetrahydropyridines as potent orexin receptor antagonists. Bioorganic & medicinal chemistry letters 20100301
Enantiospecific stereodivergent synthesis of trans- and cis-N(2),3-dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinolines. Chemistry, an Asian journal 20100301
{(1R,3S)-2-Benzyl-6,7-dimeth-oxy-1-phenyl-1,2,3,4-tetra-hydro-isoquinolin-3-yl}diphenyl-methanol. Acta crystallographica. Section E, Structure reports online 20100301
Trabectedin: a review of its use in soft tissue sarcoma and ovarian cancer. Drugs 20100212
Pictet-Spengler reactions for the synthesis of pharmaceutically relevant heterocycles. Current opinion in drug discovery & development 20100101
Integration of deep transcriptome and proteome analyses reveals the components of alkaloid metabolism in opium poppy cell cultures. BMC plant biology 20100101
Trabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis. Marine drugs 20100101
Induction of heme oxygenase-1 attenuates lipopolysaccharide-induced cyclooxygenase-2 expression in mouse brain endothelial cells. Journal of neuroinflammation 20100101
New developments in treatment of ovarian carcinoma: focus on trabectedin. Cancer management and research 20100101
[Bioactivity diversity and functional mechanism of tetrahydroisoquinoline alkaloids]. Yao xue xue bao = Acta pharmaceutica Sinica 20100101
Biochemistry and occurrence of o-demethylation in plant metabolism. Frontiers in physiology 20100101
A highly enantioselective access to tetrahydroisoquinoline and beta-carboline alkaloids with simple noyori-type catalysts in aqueous media. Chemistry (Weinheim an der Bergstrasse, Germany) 20091207
Upregulation of PTEN by CKD712, a synthetic tetrahydroisoquinoline alkaloid, selectively inhibits lipopolysaccharide-induced VCAM-1 but not ICAM-1 expression in human endothelial cells. Atherosclerosis 20091201
A class of novel N-(3S-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)-L-amino acid derivatives: their synthesis, anti-thrombotic activity evaluation, and 3D QSAR analysis. European journal of medicinal chemistry 20091201
(1R,3S)-Methyl 2-benzyl-6,7-dimeth-oxy-1-phenyl-1,2,3,4-tetra-hydro-isoquinoline-3-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20091201
Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists. Bioorganic & medicinal chemistry letters 20091101
Graphite-supported gold nanoparticles as efficient catalyst for aerobic oxidation of benzylic amines to imines and N-substituted 1,2,3,4-tetrahydroisoquinolines to amides: synthetic applications and mechanistic study. Chemistry, an Asian journal 20091005
Selective functionalization of sp(3) C-H bonds adjacent to nitrogen using (diacetoxyiodo)benzene (DIB). The Journal of organic chemistry 20091002
Facile synthesis and in vitro properties of 1-alkyl- and 1-alkyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline derivatives on PC12 cells. European journal of medicinal chemistry 20091001
Estimation of relationship between descriptors and cytotoxicity of newly synthesized 1,2,3,4-tetrahydroisoquinoline derivatives. Anticancer research 20091001
Oxaziridine-mediated intramolecular amination of sp(3)-hybridized C-H bonds. Journal of the American Chemical Society 20090909
The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin. Marine drugs 20090901
Bioactivity-guided mapping and navigation of chemical space. Nature chemical biology 20090801
Tumor-specific cytotoxic activity of 1,2,3,4-tetrahydroisoquinoline derivatives against human oral squamous cell carcinoma cell lines. Anticancer research 20090801
Chemical diversity and defence metabolism: how plants cope with pathogens and ozone pollution. International journal of molecular sciences 20090801
Molecular pharmacology and antitumor activity of Zalypsis in several human cancer cell lines. Biochemical pharmacology 20090715
Zalypsis (PM00104) is a potent inducer of gamma-H2AX foci and reveals the importance of the C ring of trabectedin for transcription-coupled repair inhibition. Molecular cancer therapeutics 20090701
(S)-Methyl 2-[(3R,4R)-2-benzyl-3-(2-fur-yl)-1-oxo-1,2,3,4-tetra-hydro-isoquinoline-4-carboxamido]-3-(1H-indol-3-yl)propanoate. Acta crystallographica. Section E, Structure reports online 20090701
A potential role of alkaloid extracts from Salsola species (Chenopodiaceae) in the treatment of Alzheimer's disease. Journal of enzyme inhibition and medicinal chemistry 20090601
Estimation of relationship between the structure of 1,2,3,4-tetrahydroisoquinoline derivatives determined by a semiempirical molecular-orbital method and their cytotoxicity. Anticancer research 20090601
Methyl trans-(±)-1-oxo-2-phenethyl-3-(thio-phen-2-yl)-1,2,3,4-tetra-hydro-isoquinoline-4-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20090601
Fast and sensitive liquid chromatography/electrospray mass spectrometry method to study ocular penetration of EDL-155, a novel antitumor agent for retinoblastoma in rats. Journal of mass spectrometry : JMS 20090501
Capillary electrophoretic study of small, highly sulfated, non-sugar molecules interacting with antithrombin. Electrophoresis 20090501
Biosynthesis of 3-hydroxy-5-methyl-o-methyltyrosine in the saframycin/ safracin biosynthetic pathway. Journal of microbiology and biotechnology 20090501
Facile synthesis of a benzindenoazepine alkaloid, bulgaramine, via samarium diiodide promoted ring expansion of an alpha-aminocarbonyl compound. Organic letters 20090416
Atropisomeric small molecule Bcl-2 ligands: determination of bioactive conformation. Bioorganic & medicinal chemistry letters 20090315
Enantioselective synthesis of schulzeines B and C via a beta-lactone-derived surrogate for bishomoserine aldehyde. Organic letters 20090305
The synthesis of N-phenoxyethyl-1-substituted-1,2,3,4-tetrahydroisoquinolines and their alpha1-adrenoceptor blocking activity. European journal of medicinal chemistry 20090301
Development of Yondelis (trabectedin, ET-743). A semisynthetic process solves the supply problem. Natural product reports 20090301
The mechanisms of oxidative DNA damage and apoptosis induced by norsalsolinol, an endogenous tetrahydroisoquinoline derivative associated with Parkinson's disease. Journal of neurochemistry 20090101
Application of the statistical methods in systematic structure-activity relationship analysis of thiazole, benzothiazole and tetrahydroisoquinoline derivatives with biological activity. Acta poloniae pharmaceutica 20090101
Solution-phase parallel annulation of (thio)hydantoins to tetrahydroisoquinolines and tetrahydro-beta-carbolines containing the 2-arylethyl amine scaffold. Journal of combinatorial chemistry 20090101
ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines. PloS one 20090101
Treatment with 1,2,3,4,-tetrahydroisoquinoline affects glutamate release in the striatum but not the binding of [3H]MK-801 to NMDA receptors in the dopaminergic structures of the rat brain. Pharmacological reports : PR 20090101
Possible treatment concepts for the levodopa-related hyperhomocysteinemia. Cardiovascular psychiatry and neurology 20090101
Role of trabectedin in the treatment of soft tissue sarcoma. OncoTargets and therapy 20090101
Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma. Core evidence 20090101
A concise total synthesis of (-)-quinocarcin via aryne annulation. Journal of the American Chemical Society 20081224
Synthetic studies on Et-743. Assembly of the pentacyclic core and a formal total synthesis. The Journal of organic chemistry 20081219
Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain. Journal of neurochemistry 20081201
Recent progress in the total synthesis of naphthyridinomycin and lemonomycin tetrahydroisoquinoline antitumor antibiotics (TAAs). Chemical Society reviews 20081201
Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. European journal of pharmacology 20081119
Synthesis of chiral 3-methyl- and 3-methyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline and prevention of MPP+ -induced cytotoxicity. Medicinal chemistry (Shariqah (United Arab Emirates)) 20081101
Synthesis and preliminary biological evaluation of new carbon-11 labeled tetrahydroisoquinoline derivatives as SERM radioligands for PET imaging of ER expression in breast cancer. European journal of medicinal chemistry 20081001
HO-1 and JAK-2/STAT-1 signals are involved in preferential inhibition of iNOS over COX-2 gene expression by newly synthesized tetrahydroisoquinoline alkaloid, CKD712, in cells activated with lipopolysacchride. Cellular signalling 20081001
Effects, in an in-vivo model system, of 1,2,3,4-tetrahydroisoquinoline on glioma. Anti-cancer drugs 20081001
Analogs of tetrahydroisoquinoline natural products that inhibit cell migration and target galectin-3 outside of its carbohydrate-binding site. The Journal of biological chemistry 20080905
Copper-catalyzed oxidative sp3 C-H bond arylation with aryl boronic acids. Organic letters 20080904
N-Methyl-isosalsoline from Hammada scoparia. Acta crystallographica. Section E, Structure reports online 20080901
Enantioselective synthesis of (R)-(+)- and (S)-(-)-higenamine and their analogues with effects on platelet aggregation and experimental animal model of disseminated intravascular coagulation. Bioorganic & medicinal chemistry letters 20080715
Concise synthesis of the CDE ring system of tetrahydroisoquinoline alkaloids using carbophilic Lewis acid-catalyzed hydroamidation and oxidative Friedel-Crafts cyclization. The Journal of organic chemistry 20080704
Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer. Bioorganic & medicinal chemistry letters 20080615
Syntheses of tetrahydroisoquinoline derivatives that inhibit NO production in activated BV-2 microglial cells. European journal of medicinal chemistry 20080601
Simultaneous analysis of 1,2,3,4-tetrahydroisoquinolines by high-performance liquid chromatography using 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride as a fluorescent labeling reagent. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080501
SAR studies of capsazepinoid bronchodilators. Part 1: The importance of the catechol moiety and aspects of the B-ring structure. Bioorganic & medicinal chemistry 20080301
New 1,2,3,4-tetrahydroisoquinoline derivatives as modulators of proteolytic cleavage of amyloid precursor proteins. Bioorganic & medicinal chemistry 20080215
Synthesis of carbon-11 labeled 1-(3,4-dimethoxybenzyl)-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolinium derivatives as new potential PET SKCa channel imaging agents. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20080201
Solution-phase parallel synthesis of novel 1,2,3,4-tetrahydroisoquinoline-1-ones as anticonvulsant agents. Chemical & pharmaceutical bulletin 20080201
Trabectedin and its potential in the treatment of soft tissue sarcoma. Therapeutics and clinical risk management 20080201
Metabolism of praziquantel in kingfish Seriola lalandi. Diseases of aquatic organisms 20080124
Discovery of a potent and long-acting bronchorelaxing capsazepinoid, RESPIR 4-95. Pulmonary pharmacology & therapeutics 20080101
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives. Bioorganic & medicinal chemistry 20080101
Synthesis of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines and comparison with their isosteric 1,2,3,4-tetrahydroisoquinolines as inhibitors of phenylethanolamine N-methyltransferase. Bioorganic & medicinal chemistry 20080101
Selective androgen receptor modulators in preclinical and clinical development. Nuclear receptor signaling 20080101
A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens. British journal of cancer 20071217
Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo. The Journal of pharmacy and pharmacology 20071201
Synthesis and antifungal activities of novel 2-aminotetralin derivatives. Journal of medicinal chemistry 20071101
Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase. Journal of medicinal chemistry 20071004
Synthesis of carbon-11 labeled biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues as new potential PET glioma tumor imaging agents. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20071001
Fatty acyl amides of endogenous tetrahydroisoquinolines are active at the recombinant human TRPV1 receptor. Bioorganic & medicinal chemistry 20070915
Cardioprotective effects of novel tetrahydroisoquinoline analogs of nitrobenzylmercaptopurine riboside in an isolated perfused rat heart model of acute myocardial infarction. American journal of physiology. Heart and circulatory physiology 20070601
Determination of a potent non-competitive AMPA receptor antagonist in rat brain. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501
Synthesis and in vitro evaluation of tetrahydroisoquinolinyl benzamides as ligands for sigma receptors. Bioorganic & medicinal chemistry letters 20070501
Identification of a series of tetrahydroisoquinoline derivatives as potential therapeutic agents for breast cancer. Bioorganic & medicinal chemistry letters 20070501
Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophore. Bioorganic & medicinal chemistry letters 20070201
Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h]isoquinoline inhibitors. Bioorganic & medicinal chemistry 20070201
The effect of modulation of gamma-glutamyl transpeptidase and nitric oxide synthase activity on GSH homeostasis in HepG2 cells. Fundamental & clinical pharmacology 20070201
Isothiazoloquinolones with enhanced antistaphylococcal activities against multidrug-resistant strains: effects of structural modifications at the 6-, 7-, and 8-positions. Journal of medicinal chemistry 20070125
Cytotoxicity of 17 tetrahydroisoquinoline derivatives in SH-SY5Y human neuroblastoma cells is related to mitochondrial NADH-ubiquinone oxidoreductase inhibition. Neurotoxicology 20070101
Effects of higenamine and its 1-naphthyl analogs, YS-49 and YS-51, on platelet TXA2 synthesis and aggregation. Thrombosis research 20070101
Quantitative structure-activity relationship modeling of growth hormone secretagogues agonist activity of some tetrahydroisoquinoline 1-carboxamides. Chemical biology & drug design 20070101
Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons. PloS one 20070101
IBX-mediated oxidative Ugi-type multicomponent reactions: application to the N and C1 functionalization of tetrahydroisoquinoline. Angewandte Chemie (International ed. in English) 20070101
Engineering the melanocortin-4 receptor to control constitutive and ligand-mediated G(S) signaling in vivo. PloS one 20070101
Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD? Behavioral and brain functions : BBF 20070101
Stereochemical diversity in asymmetric cyclization via memory of chirality. Journal of the American Chemical Society 20061206
Synthesis and radioligand binding studies of methoxylated 1,2,3,4-tetrahydroisoquinolinium derivatives as ligands of the apamin-sensitive Ca2+-activated K+ channels. Journal of medicinal chemistry 20061130
Syntheses of aporphine and homoaporphine alkaloids by intramolecular ortho-arylation of phenols with aryl halides via SRN1 reactions in liquid ammonia. The Journal of organic chemistry 20061027
Solid-phase synthesis of tetrahydro-beta-carbolines and tetrahydroisoquinolines by stereoselective intramolecular N-carbamyliminium Pictet-Spengler reactions. Chemistry (Weinheim an der Bergstrasse, Germany) 20061025
Design, synthesis, and antifungal activities in vitro of novel tetrahydroisoquinoline compounds based on the structure of lanosterol 14alpha-demethylase (CYP51) of fungi. Bioorganic & medicinal chemistry letters 20061015
Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries. Biochemical and biophysical research communications 20061013
De novo biosynthesis of morphine in animal cells: an evidence-based model. Medical science monitor : international medical journal of experimental and clinical research 20061001
Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues. Journal of medicinal chemistry 20060921
Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase. Journal of medicinal chemistry 20060907
Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton. Journal of medicinal chemistry 20060907
Random chemistry as a new tool for the generation of small-compound libraries. Archiv der Pharmazie 20060901
Affinity of 1-aryl-1,2,3,4-tetrahydroisoquinoline derivatives to the ion channel binding site of the NMDA receptor complex. European journal of medicinal chemistry 20060801
[Asymmetric intramolecular conjugate addition of chiral enolates via non-equilibrium]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060801
Synthetic studies on Et-743. Asymmetric, stereocontrolled construction of the tetrahydroisoquinoline core via radical cyclization on a glyoxalimine. Organic letters 20060720
Synthesis and SAR of novel histamine H3 receptor antagonists. Bioorganic & medicinal chemistry letters 20060701
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents. Archiv der Pharmazie 20060701
Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G. Bioorganic & medicinal chemistry letters 20060615
Synthesis of new and potent analogues of anti-tuberculosis agent 5-nitro-furan-2-carboxylic acid 4-(4-benzyl-piperazin-1-yl)-benzylamide with improved bioavailability. Bioorganic & medicinal chemistry letters 20060515
The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity. Journal of neurochemistry 20060501
Acetylcholinesterase inhibitors from Stephania venosa tuber. The Journal of pharmacy and pharmacology 20060501
Development of the Pictet-Spengler reaction catalyzed by AuCl3/AgOTf. The Journal of organic chemistry 20060317
1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors. Bioorganic & medicinal chemistry letters 20060315
1-Benzyl-1,2,3,4-tetrahydroisoquinoline-6,7-diols as novel affinity and photoaffinity probes for beta-adrenoceptor subtypes. Bioorganic & medicinal chemistry 20060315
The solution to a deep stereochemical conundrum: studies toward the tetrahydroisoquinoline alkaloids. Angewandte Chemie (International ed. in English) 20060303
1-Benzyl-1,2,3,4-tetrahydroisoquinoline passes through the blood-brain barrier of rat brain: an in vivo microdialysis study. Neuroscience letters 20060227
Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline derivatives. European journal of medicinal chemistry 20060201
Capillary liquid chromatography-tandem mass spectrometry of tetrahydroisoquinoline derived neurotoxins: a study on the blood-brain barrier of rat brain. Journal of chromatography. A 20060127
Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766. Drugs in R&D 20060101
[Syntheses and ring-closures of difunctional tetrahydroisoquinolines]. Acta pharmaceutica Hungarica 20060101
[Synthesis of isothioureas derived from tetrahydroisoquinoline and NOS inhibitory activity]. Yao xue xue bao = Acta pharmaceutica Sinica 20051101
Synthesis of the tetrahydroisoquinoline alkaloid (+/-)-renieramycin G and A (+/-)-lemonomycinone analogue from a common intermediate. Journal of the American Chemical Society 20050914
P2X(7) receptor: Death or life? Purinergic signalling 20050901
Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying Parkinson's disease. Biological & pharmaceutical bulletin 20050801
Alkaloids from Alangium javanicum and Alangium grisolleoides that mediate Cu2+-dependent DNA strand scission. Journal of natural products 20050801
Synthesis and radioligand binding studies of C-5- and C-8-substituted 1-(3,4-dimethoxybenzyl)-2,2-dimethyl-1,2,3,4-tetrahydroisoquinoliniums as SK channel blockers related to N-methyl-laudanosine and N-methyl-noscapine. Journal of medicinal chemistry 20050728
1,2,3,4-Tetrahydroisoquinoline protects terminals of dopaminergic neurons in the striatum against the malonate-induced neurotoxicity. Brain research 20050727
Treatment with 1,2,3,4-tetrahydroisoquinolone affects the levels of nitric oxide, S-nitrosothiols, glutathione and the enzymatic activity of gamma-glutamyl transpeptidase in the dopaminergic structures of rat brain. Brain research 20050712
SPE-HPLC determination of new tetrahydroisoquinoline derivatives in rat plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050705
Synthesis of a novel class of fatty acids-derived isoquinolines. Chemistry and physics of lipids 20050601
Terpenoid tetrahydroisoquinoline alkaloids emetine, klugine, and isocephaeline inhibit the activation of hypoxia-inducible factor-1 in breast tumor cells. Journal of natural products 20050601
Synthesis and structure-activity relationships of novel selective factor Xa inhibitors with a tetrahydroisoquinoline ring. Journal of medicinal chemistry 20050519
Decrease in cytosolic phospholipase A2alpha mRNA levels by reactive oxygen species via MAP kinase pathways in PC12 cells: effects of dopaminergic neurotoxins. Cellular signalling 20050501
Tetrahydroisoquinoline 1-carboxamides as growth hormone secretagogues. Bioorganic & medicinal chemistry letters 20050401
Synthesis and biological evaluation of N-methyl-laudanosine iodide analogues as potential SK channel blockers. Bioorganic & medicinal chemistry 20050215
QSAR of estrogen receptor modulators: exploring selectivity requirements for ER(alpha) versus ER(beta) binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters. Bioorganic & medicinal chemistry letters 20050215
Chiral CE separation of dopamine-derived neurotoxins. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20050201
Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands. Journal of medicinal chemistry 20050127
Discovery of novel tetrahydroisoquinoline derivatives as potent and selective factor Xa inhibitors. Bioorganic & medicinal chemistry letters 20050103
[Effect of 1,2,3,4-tetrahydroimidazo[4,5-c]pyridine and 1,2,3,4-tetrahydroisoquinoline derivatives on the behavior and the brain receptor system in rats]. Eksperimental'naia i klinicheskaia farmakologiia 20050101
Tetrahydroisoquinoline derivatives as melatonin MT2 receptor antagonists. Bioorganic & medicinal chemistry letters 20041206
Alkaloidal constituents of Mucuna pruriens seeds. Phytochemistry 20040901
Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues in clinical neuroscience 20040901
New substituted piperazines as ligands for melanocortin receptors. Correlation to the X-ray structure of 'THIQ'. Journal of medicinal chemistry 20040826
Isolation and X-ray crystal structure of tetrahydroisoquinoline alkaloids from Calycotome villosa Subsp. intermedias. Molecules (Basel, Switzerland) 20040731
Synthesis of some novel 11b-substituted pyrimido[6,1-a]-isoquinoline derivatives. Molecules (Basel, Switzerland) 20040731
Stereoselective synthesis of atropisomeric korupensamines A and B utilizing planar chiral arene chromium complex. The Journal of organic chemistry 20040611
Enantioselective total syntheses of the Ipecacuanha alkaloid emetine, the Alangium alkaloid tubulosine and a novel benzoquinolizidine alkaloid by using a domino process. Chemistry (Weinheim an der Bergstrasse, Germany) 20040607
Pivotal role of an endogenous tetrahydroisoquinoline, salsolinol, in stress- and suckling-induced release of prolactin. Annals of the New York Academy of Sciences 20040601
Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system. Brain research 20040529
Structure of hydrated clusters of tetrahydroisoquinoline [THIQ-(H2O)(n=1,3)] investigated by jet spectroscopy. The Journal of chemical physics 20040522
Potential roles of NF-kappaB and ERK1/2 in cytoprotection against oxidative cell death induced by tetrahydropapaveroline. Free radical biology & medicine 20040501
Carbazates as potent inhibitors of hormone-sensitive lipase. Bioorganic & medicinal chemistry letters 20040405
Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands. Chembiochem : a European journal of chemical biology 20040402
Comparison of four modulators of drug metabolism as protectants against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the female rat and in hepatocytes in vitro. Cancer chemotherapy and pharmacology 20040401
In vivo bioconversion of tetrahydroisoquinoline by recombinant coclaurine N-methyltransferase. Bioscience, biotechnology, and biochemistry 20040401
Ruthenium-catalyzed anti-Markovnikov hydroamination of vinylarenes. Journal of the American Chemical Society 20040310
New imide 5-HT1A receptor ligands - modification of terminal fragment geometry. Molecules (Basel, Switzerland) 20040227
Disposition of 1,2,3,4,-tetrahydroisoquinoline in the brain of male Wistar and Dark Agouti rats. Brain research 20040123
Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors. Bioorganic & medicinal chemistry letters 20040105
Synthesis and anticonvulsant properties of tetrahydroisoquinoline derivatives. Farmaco (Societa chimica italiana : 1989) 20040101
Solid-phase synthesis of 1-substituted tetrahydroisoquinoline derivatives employing BOC-protected tetrahydroisoquinoline carboxylic acids. Journal of combinatorial chemistry 20040101
Solid-phase synthesis of 1,2,3,4-tetrahydroisoquinoline derivatives employing support-bound tyrosine esters in the Pictet-Spengler reaction. Journal of combinatorial chemistry 20040101
A new efficient synthetic methodology for tetrahydroisoquinoline and tetrahydro-beta-carboline derivatives using the Pictet-Spengler reaction. Molecular diversity 20040101
Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds - 1,2,3,4-tetrahydro-isoquinoline alkaloids. Polish journal of pharmacology 20040101
In vitro interaction between ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects. British journal of cancer 20031215
Synthetic studies on ecteinascidin 743: rapid access to the fully functionalized tetrahydroisoquinoline with a bridged 10-membered sulfur containing macrocycle. Chemical communications (Cambridge, England) 20031207
Structural specificity for the inhibitory effect of calmodulin on specific 125I-omega-conotoxin GVIA binding. Neurochemical research 20031201
Possible role of interleukin-6 in PC12 cell death induced by MPP+ and tetrahydroisoquinoline. Journal of pharmacological sciences 20031201
Intermolecular, markovnikov hydroamination of vinylarenes with alkylamines. Journal of the American Chemical Society 20031126
Specific nonpeptide inhibitors of puromycin-sensitive aminopeptidase with a 2,4(1H,3H)-quinazolinedione skeleton. Chemical & pharmaceutical bulletin 20031101
The interaction of tetrahydroisoquinoline derivatives with antinociceptive action of morphine and oxotremorine in mice. Journal of neural transmission (Vienna, Austria : 1996) 20031101
The Pictet-Spengler reaction in solid-phase combinatorial chemistry. Current opinion in drug discovery & development 20031101
Synthesis and pharmacological evaluation of 1-oxo-2-(3-piperidyl)-1,2,3,4- tetrahydroisoquinolines and related analogues as a new class of specific bradycardic agents possessing I(f) channel inhibitory activity. Journal of medicinal chemistry 20031023
Organolathanide-catalyzed regioselective intermolecular hydroamination of alkenes, alkynes, vinylarenes, di- and trivinylarenes, and methylenecyclopropanes. Scope and mechanistic comparison to intramolecular cyclohydroaminations. Journal of the American Chemical Society 20031015
Debenzylation of tertiary amines using phosgene or triphosgene: an efficient and rapid procedure for the preparation of carbamoyl chlorides and unsymmetrical ureas. Application in carbon-11 chemistry. The Journal of organic chemistry 20030919
Presence of reticuline in rat brain: a pathway for morphine biosynthesis. Brain research. Molecular brain research 20030910
Renieramycin J, a highly cytotoxic tetrahydroisoquinoline alkaloid, from a marine sponge Neopetrosia sp. Journal of natural products 20030801
Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands. Journal of medicinal chemistry 20030703
Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE). Bioorganic & medicinal chemistry letters 20030616
New strategy for the synthesis of tetrahydroisoquinoline alkaloids. Organic letters 20030612
New scaffolds in the development of mu opioid-receptor ligands. Bioorganic & medicinal chemistry letters 20030505
Tetrahydroisoquinoline alkaloids and 2-deoxyribonolactones from Aristolochia arcuata. Phytochemistry 20030401
Synthesis and pharmacological evaluation of 2-(3-piperidyl)-1,2,3,4-tetrahydroisoquinoline derivatives as specific bradycardic agents. Chemical & pharmaceutical bulletin 20030401
The potent anticancer compound ecteinascidin-743 (ET-743) as its 2-propanol disolvate. Acta crystallographica. Section C, Crystal structure communications 20030401
Synthesis and pharmacological study of Rho-kinase inhibitors: pharmacomodulations on the lead compound Fasudil. Journal of enzyme inhibition and medicinal chemistry 20030401
A short diastereoselective synthesis of the putative alkaloid jamtine, using a tandem pummerer/mannich cyclization sequence. The Journal of organic chemistry 20030207
Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists. Journal of chemical information and computer sciences 20030101
A possible physiological role for cerebral tetrahydroisoquinolines. Neurotoxicity research 20030101
Tetrahydroisoquinoline and beta-carboline alkaloids from Haloxylon articulatum (Cav.) Bunge (Chenopodiaceae). Zeitschrift fur Naturforschung. C, Journal of biosciences 20030101
Influence of acute and chronic 1,2,3,4-tetrahydroisoquinoline administration on the expression of proenkephalin mRNA in the rat striatum. Polish journal of pharmacology 20030101
A study of the influence of newly synthesized acyclonucleosides and 1,2,3,4-tetrahydroisoquinoline derivatives on deoxythymidine and deoxycytidine kinase activities in human neurofibrosarcoma and ovarian cancer. Acta biochimica Polonica 20030101
Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells. Biochemical pharmacology 20021115
Tetrahydroisoquinoline-3-carboxylate based matrix-metalloproteinase inhibitors: design, synthesis and structure-activity relationship. Bioorganic & medicinal chemistry 20021101
[Tetrahydroisoquinoline derivatives as possible Parkinson's disease-inducing substances]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20021101
Alkaloids, alcohol and Parkinson's disease. Parkinsonism & related disorders 20020901
Two optically active isoquinoline derivatives. Acta crystallographica. Section C, Crystal structure communications 20020801
Comparison of the inhibition of human and Trypanosoma cruzi prolyl endopeptidases. Bioorganic & medicinal chemistry 20020601
Tetrahydroisoquinoline derivatives of enkephalins: synthesis and properties. Biochemical pharmacology 20020515
3-D-QSAR analysis of N-(3-acyloxy-2-benzylpropyl)-N'-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline and N-(3-acyloxy-2-benzylpropyl)-N'-(4-hydroxy-3-methoxybenzyl) thioureas analogues as potent vanilloid receptor ligands. Bioorganic & medicinal chemistry 20020501
Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline. Pharmacology, biochemistry, and behavior 20020501
Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics. Chemical reviews 20020501
Active conformation of some arylpiperazine postsynaptic 5-HT(1A) receptor antagonists. European journal of medicinal chemistry 20020401
Total synthesis of (+/-)-jamtine using a thionium/N-acyliminium ion cascade. Organic letters 20020307
Relationship between lipophilicity and antitumor activity of molecule library of Mannich ketones determined by high-performance liquid chromatography, clogP calculation and cytotoxicity test. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020305
Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter. Biochemical pharmacology 20020301
Application of a new chiral derivatizing agent to the enantioseparation of secondary amino acids. Journal of chromatography. A 20020301
A convenient synthesis of 1,1-disubstituted 1,2,3,4-tetrahydroisoquinolines via Pictet-Spengler reaction using titanium(IV) isopropoxide and acetic-formic anhydride. Chemical & pharmaceutical bulletin 20020201
Identification of novel Ah receptor agonists using a high-throughput green fluorescent protein-based recombinant cell bioassay. Biochemistry 20020122
The influence of substitution at aromatic part of 1,2,3,4-tetrahydroisoquinoline on in vitro and in vivo 5-HT(1A)/5-HT(2A) receptor activities of its 1-adamantoyloaminoalkyl derivatives. Bioorganic & medicinal chemistry 20020101
Role of noradrenergic system in the mechanism of action of endogenous neurotoxin 1,2,3,4-tetrahydroisoquinoline: biochemical and functional studies. Polish journal of pharmacology 20020101
Synthesis, biological activity and molecular modeling studies of 1,2,3,4-tetrahydroisoquinoline derivatives as conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor containing a tyrosine moiety. Arzneimittel-Forschung 20020101
N-methylation underlying Parkinson's disease. Neurotoxicology and teratology 20020101
Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines. Polish journal of pharmacology 20020101
Synthesis and in vivo pharmacology of new derivatives of isothiazolo[5,4-b]pyridine of Mannich base type. Farmaco (Societa chimica italiana : 1989) 20011201
Synthesis of isoquinolines and pyridines by the palladium-catalyzed iminoannulation of internal alkynes. The Journal of organic chemistry 20011130
Total syntheses of conformationally constrained didemnin B analogues. replacements of N,O-dimethyltyrosine with L-1,2,3,4-tetrahydroisoquinoline and L-1,2,3,4-tetrahydro-7-methoxyisoquinoline. The Journal of organic chemistry 20011116
Simple isoquinoline and benzylisoquinoline alkaloids as potential antimicrobial, antimalarial, cytotoxic, and anti-HIV agents. Bioorganic & medicinal chemistry 20011101
Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum. Journal of neurochemistry 20011101
ET-743 (PharmaMar/NCI/Ortho Biotech). Current opinion in investigational drugs (London, England : 2000) 20011101
Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anti-cancer agents. Current medicinal chemistry. Anti-cancer agents 20011101
Intramolecular electrophilic aromatic substitution reactions of 2-amidoacroleins: a new method for the preparation of tetrahydroisoquinolines, tetrahydro-3-benzazepines, and hexahydro-3-benzazocines. Organic letters 20011018
Parallel synthesis and biological activity of a new class of high affinity and selective delta-opioid ligand. Bioorganic & medicinal chemistry 20011001
Stress-related polyketide metabolism of Dioncophyllaceae and Ancistrocladaceae. Journal of experimental botany 20011001
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease. Brain research bulletin 20010901
Effects of a 3-alkyl-, 4-hydroxy- and/or 8-aromatic-substituent on the phenylethanolamine N-methyltransferase inhibitor potency and alpha2-adrenoceptor affinity of 2,3,4,5-tetrahydro-1H-2-benzazepines. Bioorganic & medicinal chemistry 20010801
An unusual decarboxylative Maillard reaction between L-DOPA and D-glucose under biomimetic conditions: factors governing competition with Pictet-Spengler condensation. The Journal of organic chemistry 20010727
Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties. Journal of neurochemistry 20010701
Phenylethanolamine N-methyltransferase kinetics: bovine versus recombinant human enzyme. Bioorganic & medicinal chemistry letters 20010618
Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid. Free radical biology & medicine 20010615
Enantioselective synthesis of the AB-ring system of the antitumor antibiotic tetrazomine. The Journal of organic chemistry 20010504
Chromatographic separation and spectrometric identification of the oxidation products from a tetrahydro-isoquinoline alkaloid. Journal of pharmaceutical and biomedical analysis 20010501
Pictet-Spengler condensation of the antiparkinsonian drug L-DOPA with D-glyceraldehyde. Opposite kinetic effects of Fe3+ and Cu2+ ions and possible implications for the origin of therapeutic side effects. Bioorganic & medicinal chemistry 20010401
Salsolinol, a naturally occurring tetrahydroisoquinoline alkaloid, induces DNA damage and chromosomal aberrations in cultured Chinese hamster lung fibroblast cells. Mutation research 20010301
Synthesis and structure-activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acid and related pharmacophores. European journal of medicinal chemistry 20010301
Screening of beta-2 agonists and confirmation of fenoterol, orciprenaline, reproterol and terbutaline with gas chromatography-mass spectrometry as tetrahydroisoquinoline derivatives. Journal of chromatography. B, Biomedical sciences and applications 20010210
Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke. Neuroscience letters 20010209
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 20010201
Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action. European journal of cancer (Oxford, England : 1990) 20010101
Benzolactam derivatives and their affinity for alpha 1- and alpha 2-adrenoreceptors. Archiv der Pharmazie 20010101
Opposite effect of simple tetrahydroisoquinolines on amphetamine- and morphine-stimulated locomotor activity in mice. Journal of neural transmission (Vienna, Austria : 1996) 20010101
Effects of single and repeated administration of 1,2,3,4-tetrahydroisoquinoline analogs on the binding of [11C]raclopride to dopamine D2 receptors in the mouse brain. Journal of neural transmission (Vienna, Austria : 1996) 20010101
Effect of acute administration of 1,2,3,4-tetrahydroisoquinoline on the levels of glutathione and reactive oxygen species, and on the enzymatic activity of gamma-glutamyl transpeptidase in dopaminergic structures of rat brain. Neuroscience 20010101

© 2019 Angene International Limited. All rights Reserved.